---
title: "12 Health Care Stocks Moving In Thursday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299369683.md"
description: "During Thursday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Alaunos Therapeutics (up 30%), cbdMD (up 13.84%), and Telomir Pharmaceuticals (up 11.6%). Conversely, Xenon Pharmaceuticals declined sharply by 23.7%, while Myriad Genetics fell 9.32%. Other notable movers were Exicure, Tessera Defense, PepGen, and CollPlant Biotechnologies."
datetime: "2026-09-17T21:06:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299369683.md)
  - [en](https://longbridge.com/en/news/299369683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299369683.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's After-Market Session

### Gainers

-   **Alaunos Therapeutics** (NASDAQ:TCRT) shares moved upwards by 30.0% to $2.08 during Thursday's after-market session. The company's market cap stands at $3.2 million.
-   **cbdMD** (AMEX:YCBD) stock increased by 13.84% to $0.57. The company's market cap stands at $5.2 million.
-   **Telomir Pharmaceuticals** (NASDAQ:TELO) stock rose 11.6% to $1.25. The company's market cap stands at $77.7 million.
-   **Lexaria Bioscience** (NASDAQ:LEXX) stock rose 11.18% to $3.66. The market value of their outstanding shares is at $6.5 million.
-   **XORTX Therapeutics** (NASDAQ:XRTX) stock increased by 10.84% to $1.84. The company's market cap stands at $3.2 million.
-   **Senti Biosciences** (NASDAQ:SNTI) stock moved upwards by 8.59% to $0.34. The market value of their outstanding shares is at $9.6 million.

### Losers

-   **Xenon Pharmaceuticals** (NASDAQ:XENE) shares declined by 23.7% to $43.75 during Thursday's after-market session. The market value of their outstanding shares is at $5.4 billion.
-   **Myriad Genetics** (NASDAQ:MYGN) shares fell 9.32% to $3.75. The market value of their outstanding shares is at $364.5 million.
-   **Exicure** (NASDAQ:XCUR) stock decreased by 8.79% to $1.23. The company's market cap stands at $8.7 million.
-   **Tessera Defense** (AMEX:HLSQ) shares fell 5.0% to $0.65. The company's market cap stands at $1.9 million.
-   **PepGen** (NASDAQ:PEPG) shares decreased by 4.84% to $2.83. The company's market cap stands at $200.8 million.
-   **CollPlant Biotechnologies** (NASDAQ:CLGN) stock fell 4.25% to $3.88. The company's market cap stands at $6.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CLGN.US](https://longbridge.com/en/quote/CLGN.US.md)
- [XENE.US](https://longbridge.com/en/quote/XENE.US.md)
- [PEPG.US](https://longbridge.com/en/quote/PEPG.US.md)
- [XCUR.US](https://longbridge.com/en/quote/XCUR.US.md)
- [TELO.US](https://longbridge.com/en/quote/TELO.US.md)
- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)
- [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md)
- [YCBD.US](https://longbridge.com/en/quote/YCBD.US.md)
- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [XRTX.US](https://longbridge.com/en/quote/XRTX.US.md)
- [SNTI.US](https://longbridge.com/en/quote/SNTI.US.md)
- [HLSQ.US](https://longbridge.com/en/quote/HLSQ.US.md)
- [YCBD-A.US](https://longbridge.com/en/quote/YCBD-A.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)

## Related News & Research

- [Canada's Xenon Pharmaceuticals posts smaller-than-expected Q3 net loss](https://longbridge.com/en/news/304908152.md)
- [XENE: AZK heads toward potential launch as psychiatry data and phase II pain studies approach](https://longbridge.com/en/news/304924917.md)
- [BUZZ-PepGen surges as co seeks equity raise following muscle disease drug data](https://longbridge.com/en/news/305192269.md)
- [PepGen Launches $125 Million Public Stock Offering](https://longbridge.com/en/news/305070350.md)
- [BUZZ-PepGen climbs after $125 mln equity raise for muscle disease drug](https://longbridge.com/en/news/305305475.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**